Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors.
Delombaerde D, Vulsteke C, Van de Veire N, Vervloet D, Moerman V, Van Calster L, Willems AM, Croes L, Gremonprez F, De Meulenaere A, Elzo Kraemer X, Wouters K, Peeters M, Prenen H, De Sutter J.
Delombaerde D, et al. Among authors: van de veire n.
Pharmaceuticals (Basel). 2024 Jul 21;17(7):965. doi: 10.3390/ph17070965.
Pharmaceuticals (Basel). 2024.
PMID: 39065813
Free PMC article.